The Santa Cruz Sentinel talks about a promising technology from GluMetrics Inc. that is designed to provide continuous blood sugar monitoring for in-house patients. It also seems that one day this technology might play an important part in the development of an artificial pancreas to treat diabetes.
According to the company:
All GluMetrics products are based on our core glucose sensing technology, GluGlow®. GluGlow® is a unique substance that glows in the presence of sugar. This boronic acid-based polymeric material is capable of detecting and measuring the blood sugar level of diabetics and other hospitalized patients in a way that will enable physicians to deliver higher quality care than has ever before been achieved. Such a substance has long been sought after as the “missing link” in the development of an artificial pancreas, which is likely to be the next major breakthrough in bionic physiology.
GluCath®
A device for continuously monitoring the blood sugar of hospitalized patients. Such patients include acutely ill diabetics, intensive care unit patients, and others undergoing aggressive intravenous feeding.
The GluMetrics website is all hush-hush about providing further details on this technology…
